Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery
Abstract To optimize gene delivery to myelinating Schwann cells we compared clinically relevant AAV serotypes and injection routes. AAV9 and AAVrh10 vectors expressing either EGFP or the neuropathy-associated gene GJB1/Connexin32 (Cx32) under a myelin specific promoter were injected intrathecally or...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/8e16780b5a43469086b07ce6b9a5240d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|